One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria

Nigerian Journal of Clinical Practice

Volumn 12, Issue 4, 2009, Pages 429-433

  Arewa, O P ^a  

^a NIGER DELTA UNIVERSITY   (Nigeria)

Author keywords

Blood components; Clinical audit; Inappropriate transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MALE; MEDICAL AUDIT; METHODOLOGY; NIGERIA; PLASMA; PROSPECTIVE STUDY; STANDARD; STATISTICS; TEACHING HOSPITAL; THROMBOCYTE TRANSFUSION; UTILIZATION REVIEW;

BLOOD TRANSFUSION; CLINICAL AUDIT; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; NIGERIA; PLASMA; PLATELET TRANSFUSION; PROSPECTIVE STUDIES;

EID: 72849131657     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Blachman MA, Shepherd FA, Perrault RA. Clinical use of blood, blood components and products. Can. Med Assoc J. 1979: 7; 121(1): 33-42.
2. Simpson MB. Audit criteria for transfusion practices. In Wallas CH, Muller UH (eds): The Hospital transfusion committee. A Technical Workshop, American Association of Blood Banks, Anaheim, California. 1982: 21-60.
3. Sirchia L. ed. Safe and Good Use of Blood in Surgery (SANGUIS). Use of Blood Products and Artificial Colloids in 43 European Hospitals. Luxembourg office of publication of the European Communities, 1994edn.
4. Schoeder ML, Rayner HL. Transfusion of blood and blood components. In Lee RG, Bitchel TC, Foerster JF, Athens JW, Lucjens JN. Eds; Wintrobe's Clinical Haematology. Ninth edition. Lea & Febiger Philadelphia, London 1993. Vol.1 pg. 651-700.
5. 5. Tuckfield A, Haeusler MN, Grigg AP, Metz J. Reduction of inappropriate use of blood by prospective monitoring of transfusion requests. Med J Austr 1997; 167: 473-476. (Pubitemid 27483369)
6. Ibegbulam OG. Five year audit of blood transfusion practice at the University of Ilorin Teaching Hospital, Ilorin Nigeria. West African College of Physician Dissertation 1996.
7. Repine TB, Perkins JG, Kauvar DS, Blackbone L. The use of fresh whole blood in massive transfusion. J Trauma. 2006. 60(6 Suppl.)S59-69.
8. 8. Holcomb JB, Jenkins D, Rhee P. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307-310 (Pubitemid 46254739)
9. Erslev AJ, Caro J, Scuster SJ. Is there an optimal haemoglobin level? Transf Med Rev 1989.3: 237.
10. Allen JB, Allen FB. The minimum acceptable level of haemoglobin. Int Anaesthesiol Clin 198220: 1
11. 11. Practice guidelines for component therapy: A report by the American Society for Anaesthesiology Task force on Component therapy. Anaesthesiol 1996; 84(3): 732-747. (Pubitemid 26092547)
12. Adewuyi JO. Impact of HIV-AIDS on Blood safety in Africa. Archives of Ibadan Medicine. Vol.5; (1&2): 2004.31-35.
13. Makroo RN, Raina V, Kumar P, Thakur UK. A prospective audit of transfusion requests for the use of fresh frozen plasma in a tertiary care hospital. Asian J Transf Sci. 2007. vol.1(2): 59-61.
14. Shanberge JN, Quatrrochiocchi-Longe T. Analysis of fresh frozen plasma administration with suggestions for ways to reduce usage. T Med 1992; 2: 189-194.
15. Hawkins TE, Carter JM, Hunter PM. Can mandatory pre-transfusion approval be improved? T Med. 1994; 4: 45-50.
16. Brien WF, Butler RJ, Inwood MJ. An audit of blood component therapy in a Canadian general teaching hospital. Can Med Assoc J. 1989 1, 140(7): 812-815.
17. Mohanty D, Pathare AV. Audit in Transfusion Medicine-Time to wake up. Indian J Haematol BloodTransf 1999; 17: 25.
18. World Health Organization. Clinical Use of Blood. Aide Memoire for National Health Programme- World Health Organization. WHO/EHT/04.07. April 2004.